Jeffrey E. Russel

Array ( [id] => 6594004 [patent_doc_number] => 20100048487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'NOVEL CELL PENETRATING PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/091807 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12303 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048487.pdf [firstpage_image] =>[orig_patent_app_number] => 12091807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4613149 [patent_doc_number] => 07989418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Methods for the use of branched chain amino acids' [patent_app_type] => utility [patent_app_number] => 12/089970 [patent_app_country] => US [patent_app_date] => 2006-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1754 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989418.pdf [firstpage_image] =>[orig_patent_app_number] => 12089970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149471 [patent_doc_number] => 20070049531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'GLP-1 agonist and cardiovascular complations' [patent_app_type] => utility [patent_app_number] => 11/586148 [patent_app_country] => US [patent_app_date] => 2006-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6016 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049531.pdf [firstpage_image] =>[orig_patent_app_number] => 11586148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 884559 [patent_doc_number] => 07351691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-01 [patent_title] => 'Glycopeptide phosphonate derivatives' [patent_app_type] => utility [patent_app_number] => 11/584908 [patent_app_country] => US [patent_app_date] => 2006-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23242 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351691.pdf [firstpage_image] =>[orig_patent_app_number] => 11584908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 315002 [patent_doc_number] => 07524972 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Synthetic molecules that specifically react with target sequences' [patent_app_type] => utility [patent_app_number] => 11/550275 [patent_app_country] => US [patent_app_date] => 2006-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10872 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524972.pdf [firstpage_image] =>[orig_patent_app_number] => 11550275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 81772 [patent_doc_number] => 07745400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Prevention and treatment of ocular side effects with a cyclosporin' [patent_app_type] => utility [patent_app_number] => 11/548631 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1641 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745400.pdf [firstpage_image] =>[orig_patent_app_number] => 11548631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 159674 [patent_doc_number] => 07674881 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Convergent synthesis of proteins by kinetically controlled ligation' [patent_app_type] => utility [patent_app_number] => 11/545923 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 28 [patent_no_of_words] => 32693 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674881.pdf [firstpage_image] =>[orig_patent_app_number] => 11545923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4959746 [patent_doc_number] => 20080274171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Renin Inhibitors Nitroderivatives' [patent_app_type] => utility [patent_app_number] => 12/090640 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6171 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274171.pdf [firstpage_image] =>[orig_patent_app_number] => 12090640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183503 [patent_doc_number] => 20070054857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/541263 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 28913 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054857.pdf [firstpage_image] =>[orig_patent_app_number] => 11541263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 909808 [patent_doc_number] => 07329507 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-12 [patent_title] => 'Prodrug compounds with isoleucine' [patent_app_type] => utility [patent_app_number] => 11/540466 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22579 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/329/07329507.pdf [firstpage_image] =>[orig_patent_app_number] => 11540466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242855 [patent_doc_number] => 20070021350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Conjugates useful in the treatment of prostate cancer' [patent_app_type] => utility [patent_app_number] => 11/481999 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11592 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021350.pdf [firstpage_image] =>[orig_patent_app_number] => 11481999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 81763 [patent_doc_number] => 07745392 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Multi-valent guanidinium compounds for enhancing molecular translocation across cellular membranes and epithelial tissues' [patent_app_type] => utility [patent_app_number] => 11/525512 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14330 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745392.pdf [firstpage_image] =>[orig_patent_app_number] => 11525512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 272925 [patent_doc_number] => RE040850 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2009-07-14 [patent_title] => 'Analogs of parathyroid hormone' [patent_app_type] => reissue [patent_app_number] => 11/523812 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16184 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/040/RE040850.pdf [firstpage_image] =>[orig_patent_app_number] => 11523812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5136453 [patent_doc_number] => 20070078082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Methods and compositions to treat glycosaminoglycan-associated molecular interactions' [patent_app_type] => utility [patent_app_number] => 11/523811 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15184 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20070078082.pdf [firstpage_image] =>[orig_patent_app_number] => 11523811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422466 [patent_doc_number] => 20090148921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Compositions and methods for enhancing apoptosis' [patent_app_type] => utility [patent_app_number] => 11/521722 [patent_app_country] => US [patent_app_date] => 2006-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 25709 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148921.pdf [firstpage_image] =>[orig_patent_app_number] => 11521722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107650 [patent_doc_number] => 20070066528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Methods and compositions for treating polycystic ovary syndrome' [patent_app_type] => utility [patent_app_number] => 11/518574 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17566 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066528.pdf [firstpage_image] =>[orig_patent_app_number] => 11518574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5171263 [patent_doc_number] => 20070071694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Composition for oral cavity' [patent_app_type] => utility [patent_app_number] => 11/509815 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6948 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20070071694.pdf [firstpage_image] =>[orig_patent_app_number] => 11509815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688934 [patent_doc_number] => 20060287249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Crystalline forms' [patent_app_type] => utility [patent_app_number] => 11/507513 [patent_app_country] => US [patent_app_date] => 2006-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10379 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287249.pdf [firstpage_image] =>[orig_patent_app_number] => 11507513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4983406 [patent_doc_number] => 20070087965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'TREATMENT OF PSORIASIS THROUGH DOWN-REGULATION OF THE EGF-RECEPTOR WITH TOPICALLY APPLIED EGF' [patent_app_type] => utility [patent_app_number] => 11/464401 [patent_app_country] => US [patent_app_date] => 2006-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 588 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20070087965.pdf [firstpage_image] =>[orig_patent_app_number] => 11464401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 250849 [patent_doc_number] => 07582605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Phosphorus-containing hepatitis C serine protease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/503407 [patent_app_country] => US [patent_app_date] => 2006-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12191 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582605.pdf [firstpage_image] =>[orig_patent_app_number] => 11503407 [rel_patent_id] =>[rel_patent_doc_number] =>)